Rhode Island

Rhode Island has rapidly emerged as a premier northeast life sciences hub, strategically positioned between the major biotech markets of Boston and New York City.

The state's ecosystem is anchored by the Rhode Island Life Science Hub (RILSH), a central coordinating entity backed by a $45 million state investment to accelerate biotechnology innovation and wet lab development.

Rhode Island is globally recognized for its neuroscience research and oncology therapeutics, largely driven by world-class academic institutions like Brown University and the University of Rhode Island (URI).

The state offers a competitive advantage through its next-generation biomanufacturing capabilities, exemplified by Amgen's state-of-the-art facility in West Greenwich.

Emerging medtech startups and digital health firms benefit from a collaborative environment that provides innovation vouchers and access to a dense pipeline of STEM talent.

With a cost of living significantly lower than neighboring hubs, the "Ocean State" provides a sustainable landscape for pharmaceutical manufacturing and clinical trial expansion.

The recent launch of Ocean State Labs, the state's first dedicated life science incubator, further solidifies its commitment to nurturing early-stage biomedical research.

From medical device design to genomic medicine, Rhode Island's integrated healthcare network offers a unique "right-sized" environment for rapid scaling and healthcare innovation.